Spinal Trigeminal Nucleus Interpolated Part is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The spinal trigeminal nucleus interpolar part (SpVi) is a major sensory nucleus located in the brainstem's medulla oblongata, forming part of the trigeminal sensory nuclear complex. This nucleus serves as a critical relay station for processing orofacial somatosensory information, bridging peripheral trigeminal afferent inputs with higher-order cortical and subcortical targets [1][2].
The spinal trigeminal nucleus is divided into three anatomically and functionally distinct subnuclei:
The interpolar part occupies an intermediate position between the oral and caudal subnuclei, hence its name interpolar [3].
The spinal trigeminal nucleus interpolar part is situated in the ventrolateral medulla oblongata, extending from the level of the facial nucleus rostrally to the level of the obex caudally. It lies dorsal to the spinal trigeminal tract, which carries primary afferent fibers from the trigeminal nerve [1][4].
SpVi contains heterogeneous neuronal populations:
SpVi receives primary afferent input from:
Major efferent targets include:
SpVi neurons respond to:
Neurons in SpVi have well-defined receptive fields on the face, particularly around:
These receptive fields are organized somatotopically, with the perioral region represented dorsally and the mandibular region ventrally [4][8].
SpVi employs both tonic (sustained) and phasic (transient) neuronal firing patterns. Tonic neurons respond throughout stimulus application, while phasic neurons fire primarily at stimulus onset and offset. This coding allows for discrimination of stimulus duration and intensity [5][6].
SpVi plays a critical role in:
While primarily a tactile nucleus, SpVi participates in orofacial pain processing through:
SpVi connections with brainstem autonomic nuclei enable:
SpVi dysfunction has been implicated in Parkinson's disease:
Connections between SpVi and limbic structures may relate to AD pathology:
ALS affects SpVi through:
MSA with predominant cerebellar features (MSA-C) involves:
While not primarily neurodegenerative, trigeminal neuralgia involves SpVi:
While not a primary target, understanding SpVi function informs:
Current therapeutic strategies that may affect SpVi:
Sensory training approaches for orofacial dysfunction:
Ongoing studies investigate:
Key areas requiring further investigation:
The study of Spinal Trigeminal Nucleus Interpolated Part has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Purves D, Augustine GJ, Fitzpatrick D, et al. Neuroscience. 2nd edition. Sunderland (MA): Sinauer Associates; 2001. Chapter 13, Pain Sensation.
Sessle BJ. Neural mechanisms and pathways in craniofacial pain. J Orofac Pain. 1999;13(4):232-241.
Dubner R, Sessle BJ, Storey AT. The Neural Basis of Oral and Facial Function. New York: Plenum Press; 1978.
Darian-Smith I. The trigeminal system. In: Iggo A, editor. Handbook of Sensory Physiology. Berlin: Springer; 1973. p. 271-314.
Chandler SH, Goldberg LJ. Energetic related neuronal properties of jaw elevator motoneurons in the rat. J Neurophysiol. 1988;59(2):269-289.
Yoshida A, Oka T, Hidaka O, et al. The pattern of c-fos expression in the rat brainstem following electrical stimulation of the superior or inferior alveolar nerve. Arch Oral Biol. 1998;43(8):621-630.
Capra NF, Dessem D. Connections of the trigeminal motor nucleus. In: Taylor A, editor. Neurophysiology of the Jaws and Teeth. London: Macmillan; 1990. p. 288-313.
Sessle BJ, Hu JW, Amano N, et Convergence of cutaneous, tooth pulp, visceral, neck and muscle afferents onto nociceptive and non-nociceptive neurons in trigeminal subnucleus caudalis. Prog Brain Res. 1996;113:225-242.
Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197-211.
Jellinger KA. Alpha-synuclein pathology in the olfactory bulb of patients with Parkinson's disease. Acta Neuropathol. 2003;106(3):283-287.
Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217(4558):408-414.
Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942-955.
Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3(2):93-103.
Jannetta PJ. Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia. J Neurosurg. 1967;26(1):159-162.
Sindou M, Howeidy T, Acevedo G. Anatomical observations during microvascular decompression for idiopathic trigeminal neuralgia. Neurochirurgie. 2002;48(1):1-12.
Devor M, Rappaport ZH. Pain mechanisms in trigeminal neuralgia: waiting for a paradigm shift. Cephalalgia. 2000;20(4):283-286.
Jääskeläinen SK, Teerijoki-Oksa T, Forssell H. Neurophysiology and psychophysics of orofacial sensory abnormalities in trigeminal neuralgia. In: Tasker RR, editor. Stereotactic and Functional Neurosurgery. Basel: Karger; 2003. p. 123-129.